AKER News Alert Akers Biosciences (AKER) 3.13 11/13/2014 17:

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 6:28 PM

Akers Biosciences (AKER) 3.13 $AKER

Akers Biosciences Net Loss of $1.12M
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 6:18AM CST

AKER: 3.13 (+0.22)

Akers Biosciences Announces Its Financial Results for Third Quarter 2014
GlobeNewswire - Thu Nov 13, 6:05AM CST
Akers Biosciences, Inc. (Nasdaq:AKER), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the third quarter ended September 30, 2014 and for the nine months ended September 30, 2014. The Form 10-Q containing the financial statements is available for viewing on the Company's website at www.akersbiosciences.com or www.sec.gov.
AKER: 3.13 (+0.22)

Akers Biosciences Announces Conference Call to Discuss Its Third Quarter and Nine Months Financial Results
GlobeNewswire - Mon Nov 10, 6:07AM CST
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Thursday, November 13, 2014, at 10:30 a.m. Eastern Time to discuss its results for the third quarter and nine months ended September 30, 2014.
AKER: 3.13 (+0.22)

The Perils Of Value Microcap Research And The Example Of Akers Biosciences
Daniel Ward - at Seeking Alpha - Tue Nov 04, 12:22PM CST

AKER: 3.13 (+0.22)

Week In Review: Roche Seeks China Partners With First-In-Class, Best-In-Class Products
ChinaBio Today - at Seeking Alpha - Sun Oct 26, 12:46PM CDT
Featured Companies In an exclusive interview, Dr. Darren Ji (Vice President and Global Head of Roche Partnering, Asia and Emerging Markets) told ChinaBio Today that Roche ( OTCQX:RHHBY ) ( OTCPK:RHHBF ) remains entirely focused on novel drugs for...
FMI: 24.95 (-0.15), AKER: 3.13 (+0.22), WX: 37.13 (-1.35)

Akers Biosciences Announces Joint Venture to Market Rapid Diagnostic Tests in China
GlobeNewswire - Thu Oct 23, 7:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a Joint Venture Agreement (the "Joint Venture Agreement"

with Hainan Savy Investment Management Ltd ("Hainan"

and Mr. Thomas Knox ("Thomas Knox"

, the Company's Non-executive Co-Chairman (Akers, Hainan and Thomas Knox together the "Parties"

, to research, develop, produce and sell certain Akers' rapid diagnostic screening and testing products in China (the "Joint Venture"

. The Joint Venture Company will be located in Haikou, the capital city of the province of Hainan, China, and is incorporated as Hainan Savy Akers Biosciences, Ltd.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

NETGEAR, Akers Biosciences, and TOP Ships to Appear on RedChip TV on Bloomberg
GlobeNewswire - Wed Oct 08, 10:46AM CDT
RedChip Companies, Inc. ("RedChip"

, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"

TM) television program is featuring interviews with NETGEAR (Nasdaq:NTGR), Akers Biosciences (Nasdaq:AKER), and TOP Ships (Nasdaq:TOPS) this week on Bloomberg television.
TOPS: 1.66 (-0.03), AKER: 3.13 (+0.22), NTGR: 34.29 (-0.23)

Akers Biosciences Features on Global Broadcast & Online Media
GlobeNewswire - Tue Sep 16, 11:45AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that its Executive Chairman, Raymond F. Akers Jr., Ph.D, was featured on "The RedChip Money Report: Small Stocks Big Money" television program which was televised on Fox Business nationwide as well as Bloomberg Europe, UK and Asia. A recording of the globally transmitted interview regarding Akers Biosciences' business can be viewed here: http://youtu.be/5ymviBu1kno.
AKER: 3.13 (+0.22)

Police and Employers May Finally See Cannabis Breathalyzer
ACCESSWIRE - Wed Sep 10, 8:47AM CDT
Whitefish, MT / September 10, 2014 / The gradual proliferation of alcohol breathalyzer technology has helped bring down the per unit price so far that professional-grade technology, like the kind developed by Akers Biosciences, Inc. (NASDAQ: AKER), is now being marketed directly to consumers. Touted as a safety measure, as well as a means of avoiding the high cost and complications of a DUI/DWI, alcohol breathalyzers are becoming a proactive tool, used by consumers to help them more confidently enjoy an intoxicating product on their own terms.
AKER: 3.13 (+0.22), BED.VN: 0.800 (+0.010), TWD.VN: 2.520 (-0.120)

RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg
GlobeNewswire - Tue Sep 09, 1:34PM CDT
RedChip Companies, Inc. ("RedChip"

, an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report: Small Stocks Big Money"

TM) television program will feature three companies on Fox Business nationwide on Tuesday, September 9 at 10:00 p.m. Pacific (1 a.m. EDT). The show will also air on Bloomberg Europe on Sunday, September 14 at 8:30 a.m. and 3:30 p.m. GMT; on Bloomberg U.K. Sunday, September 14 at 5:00 p.m. and 8:30 p.m. GMT; and on Bloomberg Asia on Sunday September 14 at 3:30 p.m. HKT.
IQNT: 18.51 (-0.11), AKER: 3.13 (+0.22)

Akers Biosciences Presenting at US Investor Conferences
GlobeNewswire - Tue Sep 09, 12:43PM CDT
Executive Chairman Raymond F. Akers Jr., Ph.D, to present at:
AKER: 3.13 (+0.22)

Akers Biosciences Announces $864,000 Sales Contract for Its Rapid Results Point of Care Cholesterol Test
GlobeNewswire - Tue Sep 09, 6:30AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announced a contract valued at $864,000 for sales of its innovative Tri-Cholesterol "Check" tests in Australia, Singapore, the United Arab Emirates and Oman. The Company's products are being distributed in such regions by 36 Strategies General Trading LLC ("36S"

, a Dubai-based procurement solutions company. Target customers in Australia, Singapore, the United Arab Emirates and Oman include military forces, medical associations, universities and large companies operating in the resources sector.
AKER: 3.13 (+0.22)

RedChip Issues Research Update on Akers Biosciences
GlobeNewswire - Mon Aug 18, 9:10AM CDT
RedChip Companies, Inc., today announced it has issued a research update on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.13 (+0.22)

Akers Biosciences Reports Its Second Quarter Financial Results
GlobeNewswire - Tue Aug 12, 6:09AM CDT
Sales of flagship PIFA Heparin/PF4 products increasing
AKER: 3.13 (+0.22)

Akers Biosciences Announces Conference Call to Discuss Its Second Quarter and Six Months Financial Results
GlobeNewswire - Mon Aug 11, 11:17AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (AIM:AKR.L), (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, will hold a conference call on Tuesday, August 12, 2014, at 10:30 a.m. Eastern Time to discuss its results for the second quarter and six months ended June 30, 2014.
AKER: 3.13 (+0.22)

Akers Appoints New Vice President of International Sales and Marketing to Build International Business
GlobeNewswire - Tue Aug 05, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces the appointment of Nicolas Daurel as Vice President of International Sales and Marketing for Europe, the Middle East and Africa ("EMEA"

. Mr. Daurel has a twenty year track-record of successfully building and managing the sales of medical devices in EMEA, particularly within the coagulation sector.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

Akers Biosciences Signs Feasibility Study Deal With Konica Minolta to Develop Rapid Test to Aid Heart Attack Diagnoses
GlobeNewswire - Mon Jul 28, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, has signed a feasibility study deal with Konica Minolta, Inc. ("Konica Minolta"

to develop a rapid test for the early detection of cardiac muscle tissue damage - a condition commonly observed in patients suffering myocardial infarction (heart attacks). Heart attacks are the leading cause of death in U.S, with approximately 1.1 million Americans suffering heart attacks each year.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

US Patent Granted for Akers' Breath Ketone Detection Device
GlobeNewswire - Thu Jul 17, 1:00AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "Akers"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that the United States Patent and Trademark Office ("USPTO"

has granted a patent covering Akers' Breath Ketone detection device.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01)

Akers to Ring Today's NASDAQ Closing Bell
GlobeNewswire - Wed Jul 09, 7:09AM CDT
Akers Biosciences, Inc. (Nasdaq:AKER) (LSE:AKR) (the "Company" or "ABI"

, a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that the Company's Board of Directors, led by Raymond F. Akers Jr., Ph.D., Co-founder and Executive Chairman, will ring The NASDAQ Closing Bell this afternoon in celebration of Akers' January 23, 2014 listing on The NASDAQ Capital Market.
AKER: 3.13 (+0.22), AKR: 31.82 (+0.01), NDAQ: 43.79 (-0.24)

RedChip Issues Research Profile on Akers Biosciences
GlobeNewswire - Tue Jul 08, 9:03AM CDT
RedChip Companies, Inc., today announced it has issued a research profile on Akers Biosciences Inc. (Nasdaq:AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products.
AKER: 3.13 (+0.22)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...